Académique Documents
Professionnel Documents
Culture Documents
As stated earlier, the lymphocytes mature, proliferate, and differentiate in the primary or central lymphoid
organs. These lymphocytes migrate therefrom via circulation to the secondary or peripheral lymphoid organs.
Here they bind appropriate antigens and undergo further antigen-dependent differentiation.
Once in the secondary lymphoid organs, the lymphocytes do not remain there but move from one lymphoid
organ to another through the blood and lymphatic’s. The passage of lymphocytes facilitates the induction of an
immune response. These organs include the Lymph nodes, the spleen and mucosa-associated lymphoid tissue
(MALT).
1. LYMPH NODES
- Kidney shaped organs > 1cm
- During immune response, swell in size
- Fluid enters through afferent vessel
- Fluid leaves via efferent vessel
- Lymph perculates through all lymphocytes before leaving the node
- there are many afferent vessels but one efferent vessel
- Rich blood supply lets lymphocytes into the lymph nodes via the high endolthelial venues
- T-cell zone: parafollicular cortex
- B-cell zone: lymphoid follicle- mostly on the periphery of the lymph node
- During immune response, there is a massive proliferation of B cells, which leads to the formation of a
germinal centre
- Specific chemokines target their respective lymphocytes to their specific areas, e.g. T-cells to the
parafollicular cortex
- The lymph entering lymph nodes may also contain cells such as dendritic cells and macrophages
2. Spleen
- Filter for antigens in the blood
- Large organ in the abdomen
- Separated into white pulp: lymphoid cells around blood vessels, full of lymphocytes and red pulp: contains
old damaged RBC
- Any diseases involving RBC, i.e. sickle-cell, often results in an enlargement of the spleen
- T cell area: peri-arteriolar lymphatic sheath (PALS)
- B cell area is located further away from blood vessels
- Individuals who do not have a spleen are highly susceptible to infections with encapsulated bacteria.
3. Mucosal-Associated Lymphoid Tissue (MALT):
The mucous membranes lining the alimentary, respiratory, and genitourinary systems have a very large
combined surface area (about 400 m2 ), which is
The surface is constantly exposed to numerous antigens and is the major site of entry for most pathogens.
These membranes lining surfaces possess a group of organized lymphoid tissues which defend it from
pathogens and antigens.
The group of organized lymphoid tissues is known collectively as mucosal-associated lymphoid tissue
(MALT).
There are several types of MALT; the most studied one is the gut-associated lymphoid tissue (GALT)
which includes tonsils, Peyer’s patch, appendix, and loosely organised clusters of lymphoid cells in the
lamina propria of intestinal villi.
Mucosal-associated lymphoid, tissue (MALT) is functionally very significant in immune system of the body
because of the presence of large number of antibody-producing plasma cells in it.
i. Tonsils:
There are three groups of tonsil present at three different locations: palatine, lingual, and pharyngeal
(adenoids).
Palatine group of tonsil occur at the sides of the back of the mouth; lingual in the basal region of the
tongue; and pharyngeal (adenoids) in the roof of the nasopharynx (Fig. 42.5).
All the tonsil groups are nodule-like and consist of a meshwork of reticular cells and fibres interspersed
with lymphocytes, macrophages, granulocytes, and mast cells.
The B-lymphocytes are organised into follicles and germinal centres.
The germinal centres are surrounded by regions showing T-lymphocyte activity.
The tonsils protect against antigens that enter through the nausal and oral epithelial routes.
ii. Peyer’s Patch:
Peyer’s patches occur in the sub-mucosal layer present beneath the lamina propria lying under the
epithelial layer of intestinal villi.
Each Peyer’s patch is a nodule of 30-40 lymphoid follicles.
Like lymphoid follicles in other sites, those that compose Peyer’s patches can develop into secondary
follicles with germinal centres (Fig. 42.6).
1) Vaccinations
based on primary vs secondary response
primary
persons initial exposure to an antigen
lag of several days before antibodies begin being produced
peak production in ~10 days
secondary
reexposure to same pathogen triggers memory cell response
memory cells can persist for 20 years or more
much quicker response
much stronger response
2) Monoclonal Antibodies
specific B cell (with desired antibodies) is fused to cancer cell
rapid production of large numbers of the same antibody
3) Organ Transplants and Rejections
same principle as blood transfusions
usually need immunosuppressive drug therapy
TOLERANCE
Tolerance can be defined as:
1. Immunological tolerance is the failure to mount an immune response to an antigen.
2. an active physiological process producing immunological unresponsiveness to an otherwise
immunogenic substance
Tolerance is of two types:
a) Natural or "self" tolerance. This is the failure (a good thing) to attack the body's own proteins and
other antigens. If the immune system should respond to "self", an autoimmune disease may result.
b) Induced tolerance. This is tolerance to external antigens. Examples:
o deliberately manipulating the immune system to protect us from unpleasant, even dangerous,
allergic reactions to such things as food (e.g. peanuts), insect stings, grass pollen (hay fever).
o deliberately manipulating the immune system to enable transplanted organs (e.g., kidney, heart,
liver) to survive in their new host; that is, to avoid graft rejection.
o Preventing the immune system from mounting an inflammatory attack against the vast numbers
of harmless (even beneficial) bacteria living in the intestine.